Jointown Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the digital pharmaceutical distribution and supply chain business in China. It operates through Distribution, Industrial, Retail, Medical and Health, and Other divisions. The company offers distribution, warehousing, medical and pharmaceutical logistics, and other services to pharmaceutical manufacturers; medicines and health products; medical, health, and technology value-added services; and digital logistics technology and supply chain solutions. It is also involved in the operation and franchising of retail pharmacy networks; general agency brand promotion business; pharmaceutical OEM business; and wholesale of medical devices. Jointown Pharmaceutical Group Co., Ltd was founded in 1999 and is headquartered in Wuhan, China.
Research context
Jointown Pharmaceutical Group Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Distribution
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Jointown Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 13.6% below its 200 day moving average.
From a valuation standpoint, the stock is 96.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Jointown Pharmaceutical Group Co., Ltd's total revenue rose by 16.1% to $29B since the same quarter in the previous year.
Its net income has increased by 220.4% to $882M since the same quarter in the previous year.
Finally, its free cash flow grew by 850.9% to $799M since the same quarter in the previous year.
Based on the above factors, Jointown Pharmaceutical Group Co., Ltd gets an overall score of 4/5.